According to a study by Gucalp [8], male breast cancer is almost exclusively hormone receptor positive (+), including androgen receptor (AR), and is associated with a higher prevalence of BRCA2 germline mutations, particularly in men at an increased risk for developing high-risk breast cancer. The gene discussed is AR; the disease is breast carcinoma.